Free Trial

SAB Biotherapeutics (SABS) Institutional Ownership

SAB Biotherapeutics logo
$3.90 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$3.74 -0.16 (-4.10%)
As of 05/22/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for SAB Biotherapeutics (NASDAQ:SABS)

Current
Institutional Ownership
Percentage
7.82%
Number of
Institutional Buyers
(last 12 months)
31
Total
Institutional Inflows
(last 12 months)
$74.09M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$127.53K
Get SABS Insider Trade Alerts

Want to know when executives and insiders are buying or selling SAB Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

SABS Institutional Buying and Selling by Quarter

SAB Biotherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE55,697$213K0.0%+424.8%0.109%
5/19/2026 Stempoint Capital LP375,000$1.44M0.3%+155.9%0.736%
5/15/2026 OMERS ADMINISTRATION Corp29,700$114K0.0%-29.3%0.058%
5/15/2026 Affinity Asset Advisors LLC575,000$2.20M0.1%N/A1.129%
5/14/2026 Monashee Investment Management LLC500,000$1.92M1.0%N/A0.981%
5/8/2026 PNC Financial Services Group Inc.7,700$29K0.0%N/A0.015%
4/30/2026 Kestra Advisory Services LLC61,741$236K0.0%+434.6%0.121%
4/27/2026 Simplify Asset Management Inc.187,230$717K0.0%-10.1%0.367%
2/18/2026 Perceptive Advisors LLC803,210$3.00M0.1%N/A1.687%
2/18/2026 Millennium Management LLC324,090$1.21M0.0%N/A0.681%
2/18/2026 Balyasny Asset Management L.P.475,439$1.78M0.0%N/A0.999%
2/17/2026 ADAR1 Capital Management LLC26,344$99K0.0%+75.6%0.055%
2/17/2026 ExodusPoint Capital Management LP86,113$322K0.0%N/A0.181%
2/17/2026 Persistent Asset Partners Ltd19,790$74K0.0%N/A0.042%
2/16/2026 OMERS ADMINISTRATION Corp42,000$157K0.0%N/A0.088%
2/16/2026 Spruce Street Capital LP2,198,502$8.22M2.7%N/A4.618%
2/16/2026 Verition Fund Management LLC26,867$100K0.0%N/A0.056%
2/16/2026 Fifth Lane Capital LP15,000$56K0.0%N/A0.032%
2/13/2026 Marshall Wace LLP236,460$884K0.0%N/A0.497%
2/13/2026 State Street Corp13,122$49K0.0%N/A0.028%
2/11/2026 Propel Bio Management LLC652,881$2.44M2.1%N/A1.371%
2/11/2026 State of Wyoming8,971$34K0.0%N/A0.019%
2/10/2026 Goldman Sachs Group Inc.51,348$192K0.0%+357.6%0.108%
2/9/2026 Geode Capital Management LLC119,517$447K0.0%+39.4%0.251%
2/9/2026 Simplify Asset Management Inc.208,227$779K0.0%N/A0.437%
2/9/2026Jefferies Financial Group Inc.580,328$2.17M0.0%N/A1.219%
11/17/2025 Woodline Partners LP2,850,881$5.73M0.0%N/A27.383%
11/17/2025 Vivo Capital LLC11,420,000$22.95M1.8%N/A109.692%
11/17/2025 RA Capital Management L.P.4,401,500$8.85M0.1%N/A42.277%
11/17/2025 Commodore Capital LP4,401,500$8.85M0.4%N/A42.277%
11/14/2025 Virtu Financial LLC19,982$40K0.0%N/A0.192%
11/14/2025 ADAR1 Capital Management LLC15,000$30K0.0%N/A0.144%
11/12/2025 Dimensional Fund Advisors LP15,781$32K0.0%N/A0.152%
10/23/2025 HB Wealth Management LLC307,500$618K0.0%N/A2.954%
5/7/2025HB Wealth Management LLC263,200$358K0.0%+10.9%2.833%
4/29/2025Silver Oak Securities Incorporated20,188$30K0.0%N/A0.217%
4/21/2025Silver Oak Securities Incorporated20,188$30K0.0%N/A0.217%
2/17/2025Millennium Management LLC29,411$112K0.0%-43.4%0.319%
2/14/2025Northern Trust Corp11,387$43K0.0%N/A0.123%
2/14/2025Diadema Partners LP30,000$114K0.0%N/A0.325%
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
2/12/2025Geode Capital Management LLC80,234$307K0.0%+18.8%0.869%
1/15/2025HB Wealth Management LLC237,400$982K0.0%+118.6%2.572%
11/15/2024Kovitz Investment Group Partners LLC19,201$52K0.0%N/A0.208%
11/15/2024RTW Investments LP635,276$1.72M0.0%-17.2%6.883%
7/17/2024First PREMIER Bank19,386$60K0.0%N/A0.210%
5/16/2024BVF Inc. IL917,826$4.17M0.1%-90.0%9.944%
2/15/2024BVF Inc. IL9,178,282$6.31M0.2%N/A175.426%
2/14/2024Commodore Capital LP1,831,746$1.26M0.1%N/A35.024%
2/14/2024RTW Investments LP9,178,282$6.31M0.1%N/A175.493%
11/8/2023Pathstone Family Office LLC506,513$319K0.0%N/A0.968%
8/9/2023Institutional & Family Asset Management LLC192,027$159K0.0%+28.2%0.381%
2/2/2023Silver Oak Securities Incorporated51,941$31K0.0%N/A0.121%
11/7/2022Institutional & Family Asset Management LLC149,774$105K0.0%+91.7%0.348%
10/20/2022First PREMIER Bank807,535$566K0.2%+23.8%1.877%
8/15/2022LGL Partners LLC23,000$33K0.0%N/A0.054%
8/3/2022AE Wealth Management LLC18,700$27K0.0%N/A0.044%
7/26/2022First PREMIER Bank652,440$946K0.3%N/A1.519%
5/9/2022Qube Research & Technologies Ltd24,179$91K0.0%+43.8%0.056%
2/14/2022ETF Managers Group LLC13,202$105K0.0%N/A0.030%
2/10/2022Qube Research & Technologies Ltd16,817$131K0.0%N/A0.039%


SABS Institutional Ownership - Frequently Asked Questions

During the previous two years, 37 institutional investors and hedge funds held shares of SAB Biotherapeutics. The most heavily invested institutionals were Vivo Capital LLC ($22.95M), Commodore Capital LP ($8.85M), RA Capital Management L.P. ($8.85M), Spruce Street Capital LP ($8.22M), Woodline Partners LP ($5.73M), Perceptive Advisors LLC ($3.00M), and Propel Bio Management LLC ($2.44M).Learn more on SAB Biotherapeutics' institutional investors.

7.82% of SAB Biotherapeutics' stock is owned by institutional investors. Learn more on SABS's institutional investor holdings.

Of the 36 institutional investors that purchased SAB Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($11.42M), RA Capital Management L.P. ($4.40M), Commodore Capital LP ($4.40M), Woodline Partners LP ($2.85M), Spruce Street Capital LP ($2.20M), Perceptive Advisors LLC ($803.21K), and Propel Bio Management LLC ($652.88K).

Institutional investors have bought a total of 30,614,831 shares in the last 24 months. This purchase volume represents approximately $74.09M in transactions.

The following institutional investors have sold SAB Biotherapeutics stock in the last 24 months: Simplify Asset Management Inc. ($21.00K), and OMERS ADMINISTRATION Corp ($12.30K).

Institutional investors have sold a total of 33,297 shares in the last 24 months. This volume of shares sold represents approximately $127.53K in transactions.



This page (NASDAQ:SABS) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners